Q32 Bio (QTTB) Invested Capital (2023 - 2026)

Q32 Bio's Invested Capital history runs 4 years deep, the most recent figure standing at $6.2 million for Q1 2026.

• On a quarterly basis, Invested Capital rose 33.83% year-over-year to $6.2 million in Q1 2026; TTM through Mar 2026 was $24.9 million, a 168.34% increase from a year earlier, with the FY2025 full-year figure at $6.2 million, up 101.32% from the prior year.
• Invested Capital was little changed at $6.2 million in Q1 2026 per QTTB's latest filing, from $6.2 million in the prior quarter.
• Across five years, Invested Capital topped out at $6.2 million in Q1 2026 and bottomed at $878000.0 in Q4 2023.
• The 4-year median for Invested Capital is $4.7 million (2025), against an average of $4.2 million.
• Across the five-year window, Invested Capital jumped 306.52% in 2025 and jumped 33.83% in 2026, its largest moves.
• Year by year, Invested Capital stood at $878000.0 in 2023, then jumped by 252.73% to $3.1 million in 2024, then jumped by 101.32% to $6.2 million in 2025, then advanced by 0.06% to $6.2 million in 2026.
• Per Business Quant, the three latest QTTB Invested Capital figures stand at $6.2 million (Q1 2026), $6.2 million (Q4 2025), and $6.2 million (Q3 2025).